$AXON
AXON ENTERPRISE, INC.

2024 Q1 Form 10-K Financial Statement

#000106918324000006 Filed on February 27, 2024

View on sec.gov

Income Statement

Concept 2024 Q1 2023 Q4 2023
Revenue $460.7M $432.1M $1.563B
YoY Change 34.31% 28.56% 31.38%
Cost Of Revenue $200.7M $168.3M $608.0M
YoY Change 44.44% 28.97% 31.8%
Gross Profit $260.0M $263.9M $955.4M
YoY Change 27.41% 28.3% 31.12%
Gross Profit Margin 56.44% 61.06% 61.11%
Selling, General & Admin $152.7M $137.1M $496.9M
YoY Change 30.97% 19.83% 23.73%
% of Gross Profit 58.71% 51.96% 52.01%
Research & Development $91.10M $83.97M $303.7M
YoY Change 28.44% 22.19% 29.9%
% of Gross Profit 35.03% 31.82% 31.79%
Depreciation & Amortization $11.56M $10.05M $32.64M
YoY Change 72.88% 61.85% 33.87%
% of Gross Profit 4.45% 3.81% 3.42%
Operating Expenses $243.8M $221.1M $800.6M
YoY Change 30.01% 20.72% 26.0%
Operating Profit $16.28M $42.81M $154.8M
YoY Change -1.97% 89.92% 65.99%
Interest Expense $10.37M $54.89M $42.11M
YoY Change -58.96% 350.36% -59.22%
% of Operating Profit 63.72% 128.23% 27.21%
Other Income/Expense, Net $139.1M -$41.90M -$41.90M
YoY Change 790.88% -142.34%
Pretax Income $165.7M $55.80M $155.0M
YoY Change 295.66% 60.67% -21.13%
Income Tax $32.50M -$1.469M -$19.23M
% Of Pretax Income 19.61% -2.63% -12.4%
Net Earnings $133.2M $57.27M $174.2M
YoY Change 195.13% 96.3% 18.41%
Net Earnings / Revenue 28.91% 13.25% 11.14%
Basic Earnings Per Share $1.77 $2.35
Diluted Earnings Per Share $1.73 $0.75 $2.31
COMMON SHARES
Basic Shares Outstanding 75.30M 74.93M 74.20M
Diluted Shares Outstanding 77.13M 75.46M

Balance Sheet

Concept 2024 Q1 2023 Q4 2023
SHORT-TERM ASSETS
Cash & Short-Term Investments $503.6M $676.5M $1.321B
YoY Change 58.25% 72.17% 35.48%
Cash & Equivalents $403.9M $598.5M $598.5M
Short-Term Investments $99.72M $77.94M $722.0M
Other Short-Term Assets $123.7M $112.8M $112.8M
YoY Change -13.1% 54.45% 54.45%
Inventory $271.3M $269.9M $269.9M
Prepaid Expenses
Receivables $742.9M $693.5M $693.5M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $2.202B $2.397B $2.397B
YoY Change 7.26% 32.76% 32.76%
LONG-TERM ASSETS
Property, Plant & Equipment $209.2M $200.5M $236.7M
YoY Change 21.13% 18.07% 13.68%
Goodwill $250.7M $57.95M
YoY Change 457.33% 28.82%
Intangibles $89.42M $19.54M
YoY Change 693.43% 60.71%
Long-Term Investments $295.5M $231.7M $231.7M
YoY Change -9.82% -48.82% -48.82%
Other Assets $212.5M $220.6M $414.0M
YoY Change 26.34% 38.23% 48.86%
Total Long-Term Assets $1.414B $1.040B $1.040B
YoY Change 48.07% -0.61% -0.61%
TOTAL ASSETS
Total Short-Term Assets $2.202B $2.397B $2.397B
Total Long-Term Assets $1.414B $1.040B $1.040B
Total Assets $3.616B $3.437B $3.437B
YoY Change 20.22% 20.51% 20.51%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $82.08M $88.33M $88.33M
YoY Change 24.38% 47.41% 47.41%
Accrued Expenses $127.4M $188.2M $190.4M
YoY Change 5.64% 20.71% 28.0%
Deferred Revenue $516.4M $491.7M
YoY Change 26.55% 36.57%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $757.5M $800.0M $800.0M
YoY Change 22.94% 32.74% 32.74%
LONG-TERM LIABILITIES
Long-Term Debt $677.9M $677.1M $677.1M
YoY Change 0.47% 0.47% 0.47%
Other Long-Term Liabilities $3.078M $2.936M $347.7M
YoY Change -31.77% -36.35% 13.34%
Total Long-Term Liabilities $3.078M $2.936M $1.025B
YoY Change -31.77% -36.35% 4.5%
TOTAL LIABILITIES
Total Short-Term Liabilities $757.5M $800.0M $800.0M
Total Long-Term Liabilities $3.078M $2.936M $1.025B
Total Liabilities $1.798B $1.825B $1.825B
YoY Change 12.04% 15.25% 15.25%
SHAREHOLDERS EQUITY
Retained Earnings $564.5M $431.2M
YoY Change 86.81% 67.79%
Common Stock $1.421B $1.347B
YoY Change 12.6% 14.71%
Preferred Stock
YoY Change
Treasury Stock (at cost) $155.9M $155.9M
YoY Change 0.0% 0.0%
Treasury Stock Shares
Shareholders Equity $1.818B $1.612B $1.612B
YoY Change
Total Liabilities & Shareholders Equity $3.616B $3.437B $3.437B
YoY Change 20.22% 20.51% 20.51%

Cashflow Statement

Concept 2024 Q1 2023 Q4 2023
OPERATING ACTIVITIES
Net Income $133.2M $57.27M $174.2M
YoY Change 195.13% 96.3% 18.41%
Depreciation, Depletion And Amortization $11.56M $10.05M $32.64M
YoY Change 72.88% 61.85% 33.87%
Cash From Operating Activities -$15.94M $140.0M $189.3M
YoY Change -71.7% 6.8% -19.59%
INVESTING ACTIVITIES
Capital Expenditures $16.19M $24.07M $59.64M
YoY Change 90.23% 105.74% 6.87%
Acquisitions $237.8M $21.09M
YoY Change 902.38%
Other Investing Activities -$157.9M $77.24M $72.75M
YoY Change 146.5% -114.93% -109.39%
Cash From Investing Activities -$174.0M $53.17M $12.48M
YoY Change 139.49% -110.05% -101.5%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -2.710M -3.818M 41.31M
YoY Change -107.13% -100.64% -93.09%
NET CHANGE
Cash From Operating Activities -15.94M 140.0M 189.3M
Cash From Investing Activities -174.0M 53.17M 12.48M
Cash From Financing Activities -2.710M -3.818M 41.31M
Net Change In Cash -194.7M 189.4M 245.1M
YoY Change 115.75% -6.57% -27765.69%
FREE CASH FLOW
Cash From Operating Activities -$15.94M $140.0M $189.3M
Capital Expenditures $16.19M $24.07M $59.64M
Free Cash Flow -$32.13M $116.0M $129.6M
YoY Change -50.44% -2.89% -27.81%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q4 us-gaap Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List
OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent
CY2023Q4 us-gaap Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List
OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent
CY2023Q4 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#OtherLiabilitiesCurrent
CY2023 dei Entity Central Index Key
EntityCentralIndexKey
0001069183
CY2023 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2023 dei Amendment Flag
AmendmentFlag
false
CY2023 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
75301424
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
71474581
CY2022Q4 us-gaap Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List
OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent
CY2022Q4 us-gaap Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List
OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent
CY2022Q4 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#OtherLiabilitiesCurrent
CY2023 dei Document Type
DocumentType
10-K
CY2023 dei Document Annual Report
DocumentAnnualReport
true
CY2023 dei Document Period End Date
DocumentPeriodEndDate
2023-12-31
CY2023 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023 dei Document Transition Report
DocumentTransitionReport
false
CY2023 dei Entity File Number
EntityFileNumber
001-16391
CY2023 dei Entity Registrant Name
EntityRegistrantName
Axon Enterprise, Inc.
CY2023 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
86-0741227
CY2023 dei Entity Address Address Line1
EntityAddressAddressLine1
17800 North 85th Street
CY2023 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
85255
CY2023 dei Entity Address City Or Town
EntityAddressCityOrTown
Scottsdale
CY2023 dei Entity Address State Or Province
EntityAddressStateOrProvince
AZ
CY2023 dei City Area Code
CityAreaCode
480
CY2023 dei Local Phone Number
LocalPhoneNumber
991-0797
CY2023 dei Security12b Title
Security12bTitle
Common Stock, $0.00001 par value per share
CY2023 dei Trading Symbol
TradingSymbol
AXON
CY2023 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
Yes
CY2023 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2023 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2023 dei Entity Small Business
EntitySmallBusiness
false
CY2023 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
true
CY2023 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2023 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Public Float
EntityPublicFloat
14300000000
CY2024Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
75302832
CY2023 dei Auditor Firm
AuditorFirmId
248
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
598545000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
353684000
CY2023Q4 us-gaap Marketable Securities
MarketableSecurities
77940000
CY2022Q4 us-gaap Marketable Securities
MarketableSecurities
39240000
CY2023Q4 us-gaap Short Term Investments
ShortTermInvestments
644054000
CY2022Q4 us-gaap Short Term Investments
ShortTermInvestments
581769000
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
2392000
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
2176000
CY2023Q4 us-gaap Accounts Notes And Loans Receivable Net Current
AccountsNotesAndLoansReceivableNetCurrent
417690000
CY2022Q4 us-gaap Accounts Notes And Loans Receivable Net Current
AccountsNotesAndLoansReceivableNetCurrent
358190000
CY2023Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
275779000
CY2022Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
196902000
CY2023Q4 us-gaap Inventory Net
InventoryNet
269855000
CY2022Q4 us-gaap Inventory Net
InventoryNet
202471000
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
112786000
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
73022000
CY2023Q4 us-gaap Assets Current
AssetsCurrent
2396649000
CY2022Q4 us-gaap Assets Current
AssetsCurrent
1805278000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
200533000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
169843000
CY2023Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
229513000
CY2022Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
156866000
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
19539000
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
12158000
CY2023Q4 us-gaap Goodwill
Goodwill
57945000
CY2022Q4 us-gaap Goodwill
Goodwill
44983000
CY2022Q4 us-gaap Long Term Investments
LongTermInvestments
156207000
CY2023Q4 us-gaap Long Term Accounts Notes And Loans Receivable Net Noncurrent
LongTermAccountsNotesAndLoansReceivableNetNoncurrent
2588000
CY2022Q4 us-gaap Long Term Accounts Notes And Loans Receivable Net Noncurrent
LongTermAccountsNotesAndLoansReceivableNetNoncurrent
5210000
CY2023Q4 us-gaap Contract With Customer Asset Net Noncurrent
ContractWithCustomerAssetNetNoncurrent
77710000
CY2022Q4 us-gaap Contract With Customer Asset Net Noncurrent
ContractWithCustomerAssetNetNoncurrent
45170000
CY2023Q4 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
231730000
CY2022Q4 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
296563000
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
220638000
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
159616000
CY2023Q4 us-gaap Assets
Assets
3436845000
CY2022Q4 us-gaap Assets
Assets
2851894000
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
88326000
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
59918000
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
188230000
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
155934000
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
491691000
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
360037000
CY2023Q4 axon Customer Deposit Current
CustomerDepositCurrent
21935000
CY2022Q4 axon Customer Deposit Current
CustomerDepositCurrent
20399000
CY2023Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
9787000
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
6358000
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
799969000
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
602646000
CY2023Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
281852000
CY2022Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
248003000
CY2023Q4 us-gaap Liability For Uncertain Tax Positions Noncurrent
LiabilityForUncertainTaxPositionsNoncurrent
18049000
CY2022Q4 us-gaap Liability For Uncertain Tax Positions Noncurrent
LiabilityForUncertainTaxPositionsNoncurrent
10745000
CY2023Q4 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
11342000
CY2022Q4 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
6285000
CY2022Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
1000
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
33550000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
37143000
CY2023Q4 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
677113000
CY2022Q4 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
673967000
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2936000
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
4613000
CY2023Q4 us-gaap Liabilities
Liabilities
1824811000
CY2022Q4 us-gaap Liabilities
Liabilities
1583403000
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
25000000
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
25000000
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
75301424
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
71474581
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
1000
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
1000
CY2023Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1347410000
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1174594000
CY2022Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
20220227
CY2023Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
20220227
CY2023Q4 us-gaap Treasury Stock Value
TreasuryStockValue
155947000
CY2022Q4 us-gaap Treasury Stock Value
TreasuryStockValue
155947000
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
431249000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
257022000
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-10679000
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-7179000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
1612034000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
1268491000
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3436845000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2851894000
CY2023 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1563391000
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1189935000
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
863381000
CY2023 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
608009000
CY2022 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
461297000
CY2021 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
322471000
CY2023 us-gaap Gross Profit
GrossProfit
955382000
CY2022 us-gaap Gross Profit
GrossProfit
728638000
CY2021 us-gaap Gross Profit
GrossProfit
540910000
CY2023 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
496874000
CY2022 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
401575000
CY2021 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
515007000
CY2023 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
303719000
CY2022 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
233810000
CY2022 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
4294000
CY2021 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
194026000
CY2023 us-gaap Operating Expenses
OperatingExpenses
800593000
CY2022 us-gaap Operating Expenses
OperatingExpenses
635385000
CY2021 us-gaap Operating Expenses
OperatingExpenses
709033000
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
154789000
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
93253000
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-168123000
CY2023 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
42112000
CY2022 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
106176000
CY2022 us-gaap Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
48858000
CY2023 axon Stock Issued During Period Value Employee Benefit Plan Withheld For Payroll Taxes
StockIssuedDuringPeriodValueEmployeeBenefitPlanWithheldForPayrollTaxes
107894000
CY2023 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
54503000
CY2023 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
131358000
CY2021 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
1483000
CY2023 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-41901000
CY2022 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
98971000
CY2021 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
25265000
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
155000000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
196518000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-141375000
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-19227000
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
49379000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-81357000
CY2023 us-gaap Net Income Loss
NetIncomeLoss
174227000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
147139000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-60018000
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.35
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.07
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.91
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.31
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.03
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.91
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
74195000
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
71093000
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
66191000
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
75456000
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
72534000
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
66191000
CY2023 us-gaap Net Income Loss
NetIncomeLoss
174227000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
147139000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-60018000
CY2023 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-4352000
CY2022 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-4818000
CY2021 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-1251000
CY2023 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
852000
CY2022 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-1044000
CY2021 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-207000
CY2023 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
170727000
CY2022 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
141277000
CY2021 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-61476000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
976255000
CY2021 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
105514000
CY2021 axon Stock Issued During Period Value Employee Benefit Plan Withheld For Payroll Taxes
StockIssuedDuringPeriodValueEmployeeBenefitPlanWithheldForPayrollTaxes
331309000
CY2021 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
51614000
CY2021 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
303331000
CY2021 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
3920000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-60018000
CY2021 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1458000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
1047849000
CY2022 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
-74000
CY2022 axon Stock Issued During Period Value Employee Benefit Plan Withheld For Payroll Taxes
StockIssuedDuringPeriodValueEmployeeBenefitPlanWithheldForPayrollTaxes
4870000
CY2023 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
144000
CY2023 us-gaap Net Income Loss
NetIncomeLoss
174227000
CY2023 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-3500000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
1612034000
CY2023 us-gaap Profit Loss
ProfitLoss
174227000
CY2022 us-gaap Profit Loss
ProfitLoss
147139000
CY2021 us-gaap Profit Loss
ProfitLoss
-60018000
CY2023 us-gaap Share Based Compensation
ShareBasedCompensation
131358000
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
106176000
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
303331000
CY2023 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-73002000
CY2022 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
22090000
CY2022 axon Adjustments To Additional Paid In Capital Purchase Of Convertible Note Hedge
AdjustmentsToAdditionalPaidInCapitalPurchaseOfConvertibleNoteHedge
194994000
CY2022 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
124269000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
147139000
CY2022 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-5862000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
1268491000
CY2023 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
94705000
CY2023 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
32638000
CY2022 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
24381000
CY2021 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
18694000
CY2021 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-81303000
CY2023 us-gaap Gain Loss On Investments
GainLossOnInvestments
-41785000
CY2022 us-gaap Gain Loss On Investments
GainLossOnInvestments
98943000
CY2021 us-gaap Gain Loss On Investments
GainLossOnInvestments
23035000
CY2023 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
-16449000
CY2022 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
-1463000
CY2021 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
5217000
CY2023 axon Non Cash Lease Expense
NonCashLeaseExpense
6846000
CY2022 axon Non Cash Lease Expense
NonCashLeaseExpense
6725000
CY2021 axon Non Cash Lease Expense
NonCashLeaseExpense
5573000
CY2023 axon Provision For Unrecognized Tax Benefits
ProvisionForUnrecognizedTaxBenefits
4775000
CY2022 axon Provision For Unrecognized Tax Benefits
ProvisionForUnrecognizedTaxBenefits
3475000
CY2021 axon Provision For Unrecognized Tax Benefits
ProvisionForUnrecognizedTaxBenefits
-706000
CY2023 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
3126000
CY2022 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
198000
CY2023 us-gaap Other Noncash Expense
OtherNoncashExpense
2322000
CY2022 us-gaap Other Noncash Expense
OtherNoncashExpense
6530000
CY2021 us-gaap Other Noncash Expense
OtherNoncashExpense
24000
CY2023 us-gaap Increase Decrease In Accounts And Notes Receivable
IncreaseDecreaseInAccountsAndNotesReceivable
172524000
CY2022 us-gaap Increase Decrease In Accounts And Notes Receivable
IncreaseDecreaseInAccountsAndNotesReceivable
73228000
CY2021 us-gaap Increase Decrease In Accounts And Notes Receivable
IncreaseDecreaseInAccountsAndNotesReceivable
205769000
CY2023 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
71896000
CY2022 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
95987000
CY2021 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
18272000
CY2023 axon Increase Decrease In Prepaid Expense And Other Current Assets
IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets
102370000
CY2022 axon Increase Decrease In Prepaid Expense And Other Current Assets
IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets
52207000
CY2021 axon Increase Decrease In Prepaid Expense And Other Current Assets
IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets
40158000
CY2023 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
64384000
CY2022 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
80757000
CY2021 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
45301000
CY2023 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
164043000
CY2022 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
159718000
CY2021 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
175615000
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
189263000
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
235361000
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
124494000
CY2023 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
545988000
CY2022 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
764374000
CY2021 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
362479000
CY2023 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
657418000
CY2022 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
72138000
CY2021 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
718617000
CY2021 us-gaap Proceeds From Sale Of Other Investments
ProceedsFromSaleOfOtherInvestments
14546000
CY2023 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
59635000
CY2022 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
55802000
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
49886000
CY2023 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
98000
CY2022 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
287000
CY2021 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
43000
CY2023 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
635000
CY2022 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
307000
CY2021 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
392000
CY2023 axon Payments To Acquire Equity Securities Without Readily Determinable Fair Value
PaymentsToAcquireEquitySecuritiesWithoutReadilyDeterminableFairValue
17692000
CY2022 axon Payments To Acquire Equity Securities Without Readily Determinable Fair Value
PaymentsToAcquireEquitySecuritiesWithoutReadilyDeterminableFairValue
80805000
CY2021 axon Payments To Acquire Equity Securities Without Readily Determinable Fair Value
PaymentsToAcquireEquitySecuritiesWithoutReadilyDeterminableFairValue
45500000
CY2023 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
21090000
CY2022 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
2104000
CY2021 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
22393000
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
12476000
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-830967000
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
252556000
CY2023 axon Net Proceeds From Equity Offering
NetProceedsFromEquityOffering
94705000
CY2022 axon Net Proceeds From Equity Offering
NetProceedsFromEquityOffering
-74000
CY2021 axon Net Proceeds From Equity Offering
NetProceedsFromEquityOffering
105514000
CY2023 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
54503000
CY2021 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
51614000
CY2023 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
107894000
CY2022 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
4870000
CY2021 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
331309000
CY2022 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
673769000
CY2022 us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
124269000
CY2022 us-gaap Payments For Hedge Financing Activities
PaymentsForHedgeFinancingActivities
194994000
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
41314000
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
598100000
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-174181000
CY2023 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2065000
CY2022 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-3380000
CY2021 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-1982000
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
245118000
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-886000
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
200887000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
355552000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
356438000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
155551000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
600670000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
355552000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
356438000
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
598545000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
353684000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
356332000
CY2023Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
2125000
CY2022Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
1868000
CY2021Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
106000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
600670000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
355552000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
356438000
CY2023 us-gaap Interest Paid Net
InterestPaidNet
3508000
CY2023 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
64492000
CY2022 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
10508000
CY2021 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
5108000
CY2023 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
238000
CY2022 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
1056000
CY2021 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
1994000
CY2021 axon Noncashor Part Noncash Acquisition Noncash Financialor Equity Instrument Consideration Valueof Shares Issued
NoncashorPartNoncashAcquisitionNoncashFinancialorEquityInstrumentConsiderationValueofSharesIssued
3920000
CY2022 us-gaap Debt Securities Available For Sale Allowance For Credit Loss Writeoff
DebtSecuritiesAvailableForSaleAllowanceForCreditLossWriteoff
0
CY2023 us-gaap Debt Securities Available For Sale Allowance For Credit Loss Writeoff
DebtSecuritiesAvailableForSaleAllowanceForCreditLossWriteoff
0
CY2023Q4 us-gaap Restricted Cash
RestrictedCash
2100000
CY2022Q4 us-gaap Restricted Cash
RestrictedCash
1900000
CY2023Q4 axon Restricted Cash Including Prepaid Expenses And Other Assets
RestrictedCashIncludingPrepaidExpensesAndOtherAssets
2000000.0
CY2023 us-gaap Asset Impairment Charges
AssetImpairmentCharges
300000
CY2022 us-gaap Asset Impairment Charges
AssetImpairmentCharges
5300000
CY2023 axon Number Of Revenue Sources
NumberOfRevenueSources
2
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
4000000.0
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
3600000
CY2022Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
811000
CY2021Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
2822000
CY2020Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
769000
CY2023 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
1499000
CY2022 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
2209000
CY2021 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
873000
CY2023 us-gaap Product Warranty Accrual Preexisting Increase Decrease
ProductWarrantyAccrualPreexistingIncreaseDecrease
8062000
CY2022 us-gaap Product Warranty Accrual Preexisting Increase Decrease
ProductWarrantyAccrualPreexistingIncreaseDecrease
198000
CY2021 us-gaap Product Warranty Accrual Preexisting Increase Decrease
ProductWarrantyAccrualPreexistingIncreaseDecrease
2926000
CY2023Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
7374000
CY2022Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
811000
CY2021Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
2822000
CY2023 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
303700000
CY2022 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
233800000
CY2021 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
194000000.0
CY2023 axon Number Of Depository Institutions
NumberOfDepositoryInstitutions
2
CY2023Q4 axon Cash And Cash Equivalents Held At Depository Institutions With Significant Concentrations
CashAndCashEquivalentsHeldAtDepositoryInstitutionsWithSignificantConcentrations
560400000
CY2023 axon Number Of Depository Institutions
NumberOfDepositoryInstitutions
2
CY2023Q4 us-gaap Cash Surrender Value Fair Value Disclosure
CashSurrenderValueFairValueDisclosure
7600000
CY2022Q4 us-gaap Cash Surrender Value Fair Value Disclosure
CashSurrenderValueFairValueDisclosure
4300000
CY2023Q4 axon Debt Instrument Principal Amount Denomination For Fair Value Calculation
DebtInstrumentPrincipalAmountDenominationForFairValueCalculation
1000
CY2023 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
CY2023 us-gaap Net Income Loss
NetIncomeLoss
174227000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
147139000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-60018000
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
74195000
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
71093000
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
66191000
CY2023 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1261000
CY2022 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1441000
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
75456000
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
72534000
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
66191000
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.35
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.07
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.91
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.31
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.03
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.91
CY2023 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7048000
CY2022 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
9298000
CY2021 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7690000
CY2023 us-gaap Reclassifications
Reclassifications
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Reclassification of Prior Year Presentation</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:21.6pt;margin:0pt;">Certain prior year amounts have been reclassified for consistency with the current year presentation. These reclassifications are not material and had no effect on the reported results of operations. </p>
CY2023 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1563391000
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1189935000
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
863381000
CY2023 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1563391000
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1189935000
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
863381000
CY2023Q4 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
4800000
CY2023 axon Revenue From Contract With Customer Payment Due Date From Date Of Invoice
RevenueFromContractWithCustomerPaymentDueDateFromDateOfInvoice
P30D
CY2023Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
353489000
CY2022Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
242072000
CY2021Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
210174000
CY2023Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
773543000
CY2022Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
608040000
CY2021Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
451312000
CY2023 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
363341000
CY2022 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
261271000
CY2021 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
177812000
CY2023 us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
111400000
CY2023 axon Increase In Contract With Customer Asset Percentage
IncreaseInContractWithCustomerAssetPercentage
0.460
CY2023 axon Increase In Contract With Customer Liability
IncreaseInContractWithCustomerLiability
165500000
CY2023 axon Increase In Contract With Customer Liability Percentage
IncreaseInContractWithCustomerLiabilityPercentage
0.272
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
491691000
CY2023Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
281852000
CY2023Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
773543000
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
360037000
CY2022Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
248003000
CY2022Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
608040000
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
491691000
CY2023Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
281852000
CY2023Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
773543000
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
360037000
CY2022Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
248003000
CY2022Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
608040000
CY2023Q4 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
7100000000
CY2023Q4 us-gaap Capitalized Contract Cost Net Current
CapitalizedContractCostNetCurrent
46335000
CY2022Q4 us-gaap Capitalized Contract Cost Net Current
CapitalizedContractCostNetCurrent
29405000
CY2023Q4 us-gaap Capitalized Contract Cost Net Noncurrent
CapitalizedContractCostNetNoncurrent
119401000
CY2022Q4 us-gaap Capitalized Contract Cost Net Noncurrent
CapitalizedContractCostNetNoncurrent
93213000
CY2023Q4 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
165736000
CY2022Q4 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
122618000
CY2023Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
1333022000
CY2023Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
158000
CY2023Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
12641000
CY2023Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
1320539000
CY2023Q4 axon Cash Cash Equivalent And Investments Amortized Cost
CashCashEquivalentAndInvestmentsAmortizedCost
598545000
CY2023Q4 us-gaap Marketable Securities
MarketableSecurities
77940000
CY2023Q4 us-gaap Short Term Investments
ShortTermInvestments
644054000
CY2023 us-gaap Available For Sale Debt Securities Gross Unrealized Loss
AvailableForSaleDebtSecuritiesGrossUnrealizedLoss
420400000
CY2023Q4 axon Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Unrealized Losses
AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerUnrealizedLosses
138800000
CY2023Q4 axon Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Gross Unrealized Losses
AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerGrossUnrealizedLosses
300000
CY2023 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
38700000
CY2022Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
1183222000
CY2022Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
57000
CY2022Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
52379000
CY2022Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
1130900000
CY2022Q4 axon Cash Cash Equivalent And Investments Amortized Cost
CashCashEquivalentAndInvestmentsAmortizedCost
353684000
CY2022Q4 us-gaap Marketable Securities
MarketableSecurities
39240000
CY2022Q4 us-gaap Short Term Investments
ShortTermInvestments
581769000
CY2022Q4 axon Long Term Investment
LongTermInvestment
156207000
CY2022 us-gaap Available For Sale Debt Securities Gross Unrealized Loss
AvailableForSaleDebtSecuritiesGrossUnrealizedLoss
349600000
CY2022Q4 axon Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Unrealized Losses
AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerUnrealizedLosses
29700000
CY2022Q4 axon Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Gross Unrealized Losses
AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerGrossUnrealizedLosses
900000
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
3630000
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
3349000
CY2023 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1084000
CY2022 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
700000
CY2023 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
754000
CY2022 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
416000
CY2023 axon Allowance For Doubtful Accounts Receivable Other
AllowanceForDoubtfulAccountsReceivableOther
-6000
CY2022 axon Allowance For Doubtful Accounts Receivable Other
AllowanceForDoubtfulAccountsReceivableOther
3000
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
3966000
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
3630000
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
2392000
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
2176000
CY2023Q4 us-gaap Contract With Customer Asset Accumulated Allowance For Credit Loss
ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss
1516000
CY2022Q4 us-gaap Contract With Customer Asset Accumulated Allowance For Credit Loss
ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss
1360000
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Noncurrent
AllowanceForDoubtfulAccountsReceivableNoncurrent
44000
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Noncurrent
AllowanceForDoubtfulAccountsReceivableNoncurrent
94000
CY2023Q4 us-gaap Off Balance Sheet Credit Loss Liability
OffBalanceSheetCreditLossLiability
14000
CY2023Q4 axon Allowance For Expected Credit Losses On Customer Receivables
AllowanceForExpectedCreditLossesOnCustomerReceivables
3966000
CY2022Q4 axon Allowance For Expected Credit Losses On Customer Receivables
AllowanceForExpectedCreditLossesOnCustomerReceivables
3630000
CY2023Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
1843000
CY2023Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
1843000
CY2023Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
104112000
CY2022Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
72740000
CY2023Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
165743000
CY2022Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
129731000
CY2023Q4 us-gaap Inventory Net
InventoryNet
269855000
CY2022Q4 us-gaap Inventory Net
InventoryNet
202471000
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
305757000
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
247738000
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
105224000
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
77895000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
200533000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
169843000
CY2023 us-gaap Depreciation
Depreciation
28100000
CY2022 us-gaap Depreciation
Depreciation
20400000
CY2021 us-gaap Depreciation
Depreciation
15800000
CY2022Q4 us-gaap Goodwill
Goodwill
44983000
CY2023 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
12751000
CY2023 us-gaap Goodwill Purchase Accounting Adjustments
GoodwillPurchaseAccountingAdjustments
19000
CY2023 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
230000
CY2023Q4 us-gaap Goodwill
Goodwill
57945000
CY2023Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
42978000
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
25282000
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
17696000
CY2022Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
31068000
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
20729000
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
10339000
CY2022Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
1819000
CY2022Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
1819000
CY2023Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
44821000
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
25282000
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
19539000
CY2022Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
32887000
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
20729000
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
12158000
CY2023 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
4500000
CY2022 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
4000000.0
CY2021 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2900000
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
5210000
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
2375000
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
2176000
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
1814000
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
1755000
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
4366000
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
17696000
CY2022Q4 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
296563000
CY2021Q4 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
83520000
CY2023 axon Equity Securities Without Readily Determinable Fair Value Purchases
EquitySecuritiesWithoutReadilyDeterminableFairValuePurchases
16192000
CY2022 axon Equity Securities Without Readily Determinable Fair Value Purchases
EquitySecuritiesWithoutReadilyDeterminableFairValuePurchases
74606000
CY2022 us-gaap Equity Securities Without Readily Determinable Fair Value Upward Price Adjustment Annual Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount
72915000
CY2023 us-gaap Equity Securities Without Readily Determinable Fair Value Downward Price Adjustment Annual Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount
82525000
CY2022 us-gaap Equity Securities Without Readily Determinable Fair Value Downward Price Adjustment Annual Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount
1108000
CY2023 axon Equity Securities Without Readily Determinable Fair Value Exercises
EquitySecuritiesWithoutReadilyDeterminableFairValueExercises
1500000
CY2022 axon Equity Securities Without Readily Determinable Fair Value Exercises
EquitySecuritiesWithoutReadilyDeterminableFairValueExercises
66630000
CY2023Q4 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
231730000
CY2022Q4 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
296563000
axon Equity Securities Without Readily Determinable Fair Value Purchases
EquitySecuritiesWithoutReadilyDeterminableFairValuePurchases
145953000
axon Equity Securities Without Readily Determinable Fair Value Gain On Sale Of Securities
EquitySecuritiesWithoutReadilyDeterminableFairValueGainOnSaleOfSecurities
12312000
us-gaap Equity Securities Without Readily Determinable Fair Value Upward Price Adjustment Annual Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount
103890000
us-gaap Equity Securities Without Readily Determinable Fair Value Downward Price Adjustment Annual Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount
84009000
axon Equity Securities Without Readily Determinable Fair Value Exercises
EquitySecuritiesWithoutReadilyDeterminableFairValueExercises
68130000
axon Equity Securities Without Readily Determinable Fair Value Sales
EquitySecuritiesWithoutReadilyDeterminableFairValueSales
14546000
CY2023Q4 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
231730000
CY2023Q4 us-gaap Capitalized Contract Cost Net Noncurrent
CapitalizedContractCostNetNoncurrent
119401000
CY2022Q4 us-gaap Capitalized Contract Cost Net Noncurrent
CapitalizedContractCostNetNoncurrent
93213000
CY2023Q4 axon Deferred Cost Of Goods Sold
DeferredCostOfGoodsSold
43678000
CY2022Q4 axon Deferred Cost Of Goods Sold
DeferredCostOfGoodsSold
11475000
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
36155000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
38370000
CY2023Q4 us-gaap Cash Surrender Value Fair Value Disclosure
CashSurrenderValueFairValueDisclosure
7558000
CY2022Q4 us-gaap Cash Surrender Value Fair Value Disclosure
CashSurrenderValueFairValueDisclosure
4274000
CY2023Q4 axon Deferred Implementation Costs
DeferredImplementationCosts
2175000
CY2022Q4 axon Deferred Implementation Costs
DeferredImplementationCosts
3045000
CY2023Q4 axon Prepaid Expenses Deposits And Other Assets Noncurrent
PrepaidExpensesDepositsAndOtherAssetsNoncurrent
11671000
CY2022Q4 axon Prepaid Expenses Deposits And Other Assets Noncurrent
PrepaidExpensesDepositsAndOtherAssetsNoncurrent
9239000
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
220638000
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
159616000
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
125636000
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
97882000
CY2023Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
7377000
CY2022Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
3861000
CY2023Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
7374000
CY2022Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
811000
CY2023Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
5784000
CY2022Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
13559000
CY2023Q4 axon Accrued Inventory In Transit Current
AccruedInventoryInTransitCurrent
12197000
CY2022Q4 axon Accrued Inventory In Transit Current
AccruedInventoryInTransitCurrent
10548000
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
29862000
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
29273000
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
188230000
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
155934000
CY2022 us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
124269000
CY2023Q4 axon Amount Of Open Purchase Orders
AmountOfOpenPurchaseOrders
429500000
CY2023Q4 axon Other Purchase Obligation
OtherPurchaseObligation
351200000
CY2023Q4 us-gaap Loss Contingency Pending Claims Number
LossContingencyPendingClaimsNumber
5
CY2023 axon Product Claims Self Insurance
ProductClaimsSelfInsurance
5000000.0
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
132448000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
191631000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-146995000
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
22552000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
4887000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
5620000
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
155000000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
196518000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-141375000
CY2023 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
33084000
CY2022 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
10804000
CY2021 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
-331000
CY2023 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
10371000
CY2022 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
10118000
CY2021 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
85000
CY2023 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
2804000
CY2022 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
2892000
CY2021 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
-60000
CY2023 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
46259000
CY2022 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
23814000
CY2021 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
-306000
CY2023 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-61106000
CY2022 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
26238000
CY2021 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-65557000
CY2023 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-9244000
CY2022 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-2002000
CY2021 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-15266000
CY2023 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
89000
CY2022 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
-2146000
CY2021 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
478000
CY2023 axon Deferred Income Tax Expense Benefit Including Differencefor Revenue Recognition Adoption
DeferredIncomeTaxExpenseBenefitIncludingDifferenceforRevenueRecognitionAdoption
-70261000
CY2022 axon Deferred Income Tax Expense Benefit Including Differencefor Revenue Recognition Adoption
DeferredIncomeTaxExpenseBenefitIncludingDifferenceforRevenueRecognitionAdoption
22090000
CY2021 axon Deferred Income Tax Expense Benefit Including Differencefor Revenue Recognition Adoption
DeferredIncomeTaxExpenseBenefitIncludingDifferenceforRevenueRecognitionAdoption
-80345000
CY2023 axon Tax Impact Of Unrecorded Tax Liability Benefits1
TaxImpactOfUnrecordedTaxLiabilityBenefits1
4775000
CY2022 axon Tax Impact Of Unrecorded Tax Liability Benefits1
TaxImpactOfUnrecordedTaxLiabilityBenefits1
3475000
CY2021 axon Tax Impact Of Unrecorded Tax Liability Benefits1
TaxImpactOfUnrecordedTaxLiabilityBenefits1
-706000
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-19227000
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
49379000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-81357000
CY2023 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
32550000
CY2022 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
41283000
CY2021 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-29691000
CY2023 axon Income Tax Reconciliation Deduction
IncomeTaxReconciliationDeduction
106522000
CY2022 axon Income Tax Reconciliation Deduction
IncomeTaxReconciliationDeduction
4616000
CY2021 axon Income Tax Reconciliation Deduction
IncomeTaxReconciliationDeduction
205483000
CY2023 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
77350000
CY2022 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
5784000
CY2021 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
180509000
CY2023 axon Income Tax Reconciliation Deductions Research
IncomeTaxReconciliationDeductionsResearch
26204000
CY2022 axon Income Tax Reconciliation Deductions Research
IncomeTaxReconciliationDeductionsResearch
13340000
CY2021 axon Income Tax Reconciliation Deductions Research
IncomeTaxReconciliationDeductionsResearch
34376000
CY2023 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-4695000
CY2022 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
10216000
CY2021 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
8961000
CY2023 axon Income Tax Reconciliation Change In Liability For Unrecognized Tax Benefits
IncomeTaxReconciliationChangeInLiabilityForUnrecognizedTaxBenefits
4351000
CY2022 axon Income Tax Reconciliation Change In Liability For Unrecognized Tax Benefits
IncomeTaxReconciliationChangeInLiabilityForUnrecognizedTaxBenefits
3215000
CY2021 axon Income Tax Reconciliation Change In Liability For Unrecognized Tax Benefits
IncomeTaxReconciliationChangeInLiabilityForUnrecognizedTaxBenefits
10188000
CY2023 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
3658000
CY2022 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
7928000
CY2021 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-12717000
CY2023 axon Effective Income Tax Rate Reconciliation Tax Effect Of Intercompany Transactions1
EffectiveIncomeTaxRateReconciliationTaxEffectOfIntercompanyTransactions1
-2033000
CY2022 axon Effective Income Tax Rate Reconciliation Tax Effect Of Intercompany Transactions1
EffectiveIncomeTaxRateReconciliationTaxEffectOfIntercompanyTransactions1
-417000
CY2021 axon Effective Income Tax Rate Reconciliation Tax Effect Of Intercompany Transactions1
EffectiveIncomeTaxRateReconciliationTaxEffectOfIntercompanyTransactions1
96000
CY2023 us-gaap Income Tax Reconciliation Tax Credits Foreign
IncomeTaxReconciliationTaxCreditsForeign
1922000
CY2023 us-gaap Effective Income Tax Rate Reconciliation Gilti Amount
EffectiveIncomeTaxRateReconciliationGiltiAmount
1890000
CY2022 us-gaap Effective Income Tax Rate Reconciliation Gilti Amount
EffectiveIncomeTaxRateReconciliationGiltiAmount
653000
CY2021 us-gaap Effective Income Tax Rate Reconciliation Gilti Amount
EffectiveIncomeTaxRateReconciliationGiltiAmount
1250000
CY2023 axon Income Tax Reconciliation Other Permanent Difference
IncomeTaxReconciliationOtherPermanentDifference
1201000
CY2022 axon Income Tax Reconciliation Other Permanent Difference
IncomeTaxReconciliationOtherPermanentDifference
1118000
CY2021 axon Income Tax Reconciliation Other Permanent Difference
IncomeTaxReconciliationOtherPermanentDifference
592000
CY2023 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
1013000
CY2022 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
-428000
CY2021 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
-155000
CY2023 us-gaap Effective Income Tax Rate Reconciliation Fdii Amount
EffectiveIncomeTaxRateReconciliationFdiiAmount
961000
CY2022 us-gaap Effective Income Tax Rate Reconciliation Fdii Amount
EffectiveIncomeTaxRateReconciliationFdiiAmount
2597000
CY2023 axon Income Tax Reconciliation Return To Provision Adjustment
IncomeTaxReconciliationReturnToProvisionAdjustment
346000
CY2022 axon Income Tax Reconciliation Return To Provision Adjustment
IncomeTaxReconciliationReturnToProvisionAdjustment
-757000
CY2021 axon Income Tax Reconciliation Return To Provision Adjustment
IncomeTaxReconciliationReturnToProvisionAdjustment
204000
CY2023 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
751000
CY2022 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
1337000
CY2021 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
-735000
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-19227000
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
49379000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-81357000
CY2023 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.124
CY2022 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.251
CY2021 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.575
CY2023Q4 us-gaap Deferred Tax Assets In Process Research And Development
DeferredTaxAssetsInProcessResearchAndDevelopment
99746000
CY2022Q4 us-gaap Deferred Tax Assets In Process Research And Development
DeferredTaxAssetsInProcessResearchAndDevelopment
46122000
CY2023Q4 axon Deferred Tax Assets Deferred Warranty Revenue
DeferredTaxAssetsDeferredWarrantyRevenue
60206000
CY2022Q4 axon Deferred Tax Assets Deferred Warranty Revenue
DeferredTaxAssetsDeferredWarrantyRevenue
47586000
CY2023Q4 axon Deferred Tax Assets Convertible Debt Net
DeferredTaxAssetsConvertibleDebtNet
39649000
CY2022Q4 axon Deferred Tax Assets Convertible Debt Net
DeferredTaxAssetsConvertibleDebtNet
48378000
CY2023Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
16554000
CY2022Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
12826000
CY2023Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Other
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther
12264000
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Other
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther
9080000
CY2023Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
11253000
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
8652000
CY2023Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
10544000
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
15374000
CY2023Q4 axon Deferred Tax Assets Lease Liability
DeferredTaxAssetsLeaseLiability
9664000
CY2022Q4 axon Deferred Tax Assets Lease Liability
DeferredTaxAssetsLeaseLiability
9973000
CY2023Q4 us-gaap Deferred Tax Assets Investments
DeferredTaxAssetsInvestments
6109000
CY2023Q4 axon Deferred Tax Assets Amortization
DeferredTaxAssetsAmortization
4425000
CY2022Q4 axon Deferred Tax Assets Amortization
DeferredTaxAssetsAmortization
2820000
CY2023Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
2803000
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
1575000
CY2023Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
2115000
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
4874000
CY2023Q4 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
1986000
CY2022Q4 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
1279000
CY2023Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
277318000
CY2022Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
208539000
CY2023Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
14575000
CY2022Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
10272000
CY2023Q4 axon Deferred Tax Liabilities Rightofuse Asset
DeferredTaxLiabilitiesRightofuseAsset
8404000
CY2022Q4 axon Deferred Tax Liabilities Rightofuse Asset
DeferredTaxLiabilitiesRightofuseAsset
8748000
CY2023Q4 us-gaap Deferred Tax Liabilities Prepaid Expenses
DeferredTaxLiabilitiesPrepaidExpenses
2223000
CY2022Q4 us-gaap Deferred Tax Liabilities Prepaid Expenses
DeferredTaxLiabilitiesPrepaidExpenses
1119000
CY2023Q4 axon Deferred Tax Liabilities Customer Contract Asset
DeferredTaxLiabilitiesCustomerContractAsset
690000
CY2022Q4 axon Deferred Tax Liabilities Customer Contract Asset
DeferredTaxLiabilitiesCustomerContractAsset
552000
CY2023Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Goodwill
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill
313000
CY2022Q4 us-gaap Deferred Tax Liabilities Investments
DeferredTaxLiabilitiesInvestments
4615000
CY2023Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
26205000
CY2022Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
25306000
CY2023Q4 axon Deferred Tax Assets Net Of Deferred Tax Liabilities1
DeferredTaxAssetsNetOfDeferredTaxLiabilities1
251113000
CY2022Q4 axon Deferred Tax Assets Net Of Deferred Tax Liabilities1
DeferredTaxAssetsNetOfDeferredTaxLiabilities1
183233000
CY2023Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
21600000
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
26368000
CY2023Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
229513000
CY2022Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
156865000
CY2023 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
-4800000
CY2022 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
10200000
CY2023Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
25800000
CY2023Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
25800000
CY2022Q4 axon Unrecognized Tax Benefit Net Of Interest On Income Taxes Accrued1
UnrecognizedTaxBenefitNetOfInterestOnIncomeTaxesAccrued1
21492000
CY2021Q4 axon Unrecognized Tax Benefit Net Of Interest On Income Taxes Accrued1
UnrecognizedTaxBenefitNetOfInterestOnIncomeTaxesAccrued1
18249000
CY2020Q4 axon Unrecognized Tax Benefit Net Of Interest On Income Taxes Accrued1
UnrecognizedTaxBenefitNetOfInterestOnIncomeTaxesAccrued1
7657000
CY2023 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
215000
CY2022 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
232000
CY2021 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
22000
CY2023 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
6963000
CY2022 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
3343000
CY2021 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
11416000
CY2023 us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
2486000
CY2022 us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
332000
CY2021 us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
846000
CY2023Q4 axon Unrecognized Tax Benefit Net Of Interest On Income Taxes Accrued1
UnrecognizedTaxBenefitNetOfInterestOnIncomeTaxesAccrued1
25754000
CY2022Q4 axon Unrecognized Tax Benefit Net Of Interest On Income Taxes Accrued1
UnrecognizedTaxBenefitNetOfInterestOnIncomeTaxesAccrued1
21492000
CY2021Q4 axon Unrecognized Tax Benefit Net Of Interest On Income Taxes Accrued1
UnrecognizedTaxBenefitNetOfInterestOnIncomeTaxesAccrued1
18249000
CY2023Q4 us-gaap Unrecognized Tax Benefits Interest On Income Taxes Accrued
UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued
600000
CY2022Q4 us-gaap Unrecognized Tax Benefits Interest On Income Taxes Accrued
UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued
300000
CY2023 axon Effective Income Tax Rate Reconciliation Gilti Percent2018 Through2025
EffectiveIncomeTaxRateReconciliationGiltiPercent2018Through2025
0.105
CY2023 axon Effective Income Tax Rate Reconciliation Gilti Percent After2025
EffectiveIncomeTaxRateReconciliationGiltiPercentAfter2025
0.13125
CY2023 axon Debt Instrument Covenant Consolidated Leverage Ratio
DebtInstrumentCovenantConsolidatedLeverageRatio
0.10
CY2023 axon Debt Instrument Covenant Consolidated Interest Coverage Ratio
DebtInstrumentCovenantConsolidatedInterestCoverageRatio
45.61
CY2023 axon Number Of Classes Of Stock
NumberOfClassesOfStock
2
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
25000000
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
1700000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
246000000.0
CY2023Q4 us-gaap Share Price
SharePrice
220.88
CY2023Q4 axon Number Of Days Volume Weighted Average Price Per Share Considered For Conversion
NumberOfDaysVolumeWeightedAveragePricePerShareConsideredForConversion
90
CY2023 us-gaap Share Based Compensation
ShareBasedCompensation
131358000
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
106176000
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
303331000
CY2023 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
13509000
CY2022 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
25154000
CY2021 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
30586000
CY2023Q4 us-gaap Lessee Operating Lease Renewal Term
LesseeOperatingLeaseRenewalTerm
P5Y
CY2023 axon Lessee Operating Lease Termination Period
LesseeOperatingLeaseTerminationPeriod
P1Y
CY2023Q4 us-gaap Finance Lease Liability
FinanceLeaseLiability
0
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
36155000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
38370000
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
7938000
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
6357000
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
33550000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
37143000
CY2023Q4 axon Lessee Lease Liability
LesseeLeaseLiability
41488000
CY2022Q4 axon Lessee Lease Liability
LesseeLeaseLiability
43500000
CY2023 us-gaap Operating Lease Cost
OperatingLeaseCost
10025000
CY2022 us-gaap Operating Lease Cost
OperatingLeaseCost
8703000
CY2021 us-gaap Operating Lease Cost
OperatingLeaseCost
7495000
CY2023 us-gaap Operating Lease Payments
OperatingLeasePayments
8846000
CY2022 us-gaap Operating Lease Payments
OperatingLeasePayments
9216000
CY2023 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
5927000
CY2022 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
21815000
CY2023Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P7Y1M6D
CY2022Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P7Y2M12D
CY2023Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0605
CY2022Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0544
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
10234000
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
9864000
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
6218000
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
3915000
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
3855000
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
19166000
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
53252000
CY2023Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
11764000
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
41488000
CY2023 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
14500000
CY2022 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
10900000
CY2021 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
7400000
CY2023 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2
CY2023 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1563391000
CY2023 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
608009000
CY2023 us-gaap Gross Profit
GrossProfit
955382000
CY2023 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
303719000
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1189935000
CY2022 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
461297000
CY2022 us-gaap Gross Profit
GrossProfit
728638000
CY2022 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
233810000
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
863381000
CY2021 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
322471000
CY2021 us-gaap Gross Profit
GrossProfit
540910000
CY2021 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
194026000
CY2023 dei Auditor Name
AuditorName
GRANT THORNTON LLP
CY2023 dei Auditor Location
AuditorLocation
Phoenix, Arizona

Files In Submission

Name View Source Status
0001069183-24-000006-index-headers.html Edgar Link pending
0001069183-24-000006-index.html Edgar Link pending
0001069183-24-000006.txt Edgar Link pending
0001069183-24-000006-xbrl.zip Edgar Link pending
axon-20231231.xsd Edgar Link pending
axon-20231231x10k.htm Edgar Link pending
axon-20231231x10k003.jpg Edgar Link pending
axon-20231231xex21d1.htm Edgar Link pending
axon-20231231xex23d1.htm Edgar Link pending
axon-20231231xex31d1.htm Edgar Link pending
axon-20231231xex31d2.htm Edgar Link pending
axon-20231231xex32.htm Edgar Link pending
axon-20231231xex4d2.htm Edgar Link pending
axon-20231231xex97.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R100.htm Edgar Link pending
R101.htm Edgar Link pending
R102.htm Edgar Link pending
R103.htm Edgar Link pending
R104.htm Edgar Link pending
R105.htm Edgar Link pending
R106.htm Edgar Link pending
R107.htm Edgar Link pending
R108.htm Edgar Link pending
R109.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
axon-20231231_def.xml Edgar Link unprocessable
axon-20231231_lab.xml Edgar Link unprocessable
axon-20231231_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
axon-20231231x10k_htm.xml Edgar Link completed
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R88.htm Edgar Link pending
R89.htm Edgar Link pending
R9.htm Edgar Link pending
R90.htm Edgar Link pending
R91.htm Edgar Link pending
R92.htm Edgar Link pending
R93.htm Edgar Link pending
R94.htm Edgar Link pending
R95.htm Edgar Link pending
R96.htm Edgar Link pending
R97.htm Edgar Link pending
R98.htm Edgar Link pending
R99.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
axon-20231231_cal.xml Edgar Link unprocessable